Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2003
10/23/2003US20030199507 Combination of brimonidine and timolol for topical ophthalmic use
10/23/2003US20030199488 A therapeutic mixture comprising corticosteroid and a gelatinous paste; treating psoriasis, skin disorders
10/23/2003US20030199485 Novel anti-inflammatory androstane derivative
10/23/2003US20030199477 Use of gellable pharmaceutical compositions in periodontology
10/23/2003US20030199476 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof
10/23/2003US20030199466 For modulating an immune response
10/23/2003US20030199433 Pharmaceutical composition
10/23/2003US20030199431 Modified peptide nucleic acid (PNA) molecules
10/23/2003US20030199427 Increased or improved bioavailability of the active agent
10/23/2003US20030199426 Combination of a saturated or unsaturated fatty alcohol or fatty acid; a C1/C4 alkanol; a polyalcohol in particular propylenglycol; water; and optionally a monoalkylether of diethylene glycol as a permeation enhancer
10/23/2003US20030199425 Administering a drug that inhibits proliferation and cell migration, and a biocompatible protein; reduced toxicity.
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030198989 For use as a diagnostic reagent for detecting the presence or absence of a target molecule in a sample; Systematic Evolution of Ligands by EXponential enrichment (SELEX)
10/23/2003US20030198682 Encapsulation cosmetic in water soluble polysaccharides; topical applying to human skins
10/23/2003US20030198681 Method of making a protein polymer and uses of the polymer
10/23/2003US20030198678 Polynucleotide immobilized with block polyether polymer; antibodies against genetic disorders
10/23/2003US20030198677 Concentration gradient of active materials; compression; drug delivery
10/23/2003US20030198674 Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
10/23/2003US20030198670 Albuterol sulfate core and overcoatings
10/23/2003US20030198666 Side effect reduction; using mixture of insulin and adjuvant
10/23/2003US20030198665 Attaching drug to hydrophilic polymer
10/23/2003US20030198663 Phospholipid-analogous compounds
10/23/2003US20030198643 Adjuvant enhanced immunotherapy
10/23/2003US20030198633 Complexing antigen to antibodies
10/23/2003US20030198620 Method of treating amino acid metabolic disorders using recombinant adeno-associated virus virions
10/23/2003US20030198619 Mixture containing permeability intensifier; in situ gelation using nonionic surfactant
10/23/2003US20030198613 Methods of dispersing al least one coloring agent using at least one heteropolymer
10/23/2003US20030198602 Improved absorption; drug delivery
10/23/2003US20030198598 Polypeptide derivatives
10/23/2003US20030198595 Completitive binding
10/23/2003CA2849556A1 Preservation of bioactive materials by freeze dried foam
10/23/2003CA2483451A1 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance
10/23/2003CA2482448A1 Preservation of bioactive materials by freeze dried foam
10/23/2003CA2482262A1 Tissue defect dressings comprising a keratin network
10/23/2003CA2482225A1 Targeted controlled delivery compositions activated by changes in ph or salt concentration
10/23/2003CA2482216A1 Patch and process for producing the same
10/23/2003CA2482215A1 Heterogeneous protein networks crosslinked with silicone-containing links, and methods for producing them
10/23/2003CA2481996A1 Charge-balanced chemoselective linkers
10/23/2003CA2481752A1 Composition for modulating a physiological reaction or inducing an immune response
10/23/2003CA2481692A1 Method for tagging colonic residue
10/23/2003CA2481683A1 Ansamycin formulations and methods for producing and using same
10/23/2003CA2481677A1 Process for preparing a finely self-emulsifiable pharmaceutical composition
10/23/2003CA2481669A1 Preparation and use of a stable formulation of allosteric effector compounds
10/23/2003CA2481667A1 Sustained release pharmaceutical prepartations and methods for producing the same
10/23/2003CA2481595A1 Solid dispersion composition
10/23/2003CA2481420A1 Method for cleaving and deglycosylating antibodies to promote ligand binding
10/23/2003CA2481384A1 Aqueous dispersible steryl ester compositions
10/23/2003CA2481372A1 Method to inhibit cell growth using oligonucleotides
10/23/2003CA2481306A1 Metastasis modulating activity of highly sulfated oligosaccharides
10/23/2003CA2481256A1 Embryo modification and implantation
10/23/2003CA2481231A1 Colon tumor specific binding peptides
10/23/2003CA2481187A1 Formoterol and ciclesonide aerosol formulations
10/23/2003CA2481092A1 Low dose liquid entecavir formulations and use
10/23/2003CA2480883A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
10/23/2003CA2480775A1 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003CA2480763A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003CA2480759A1 Improved prodrugs of cc-1065 analogs
10/23/2003CA2480512A1 Method of reducing calcified arterial plaque buildup and cellular malfunction and for balancing ionic calcium
10/23/2003CA2480425A1 Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation
10/23/2003CA2480403A1 Drug-complex microparticles and methods of making/using same
10/23/2003CA2480365A1 Iron dextrin compounds for the treatment of iron deficiency anaemia
10/23/2003CA2480213A1 Use of interleukin-19 to treat ovarian cancer
10/23/2003CA2480176A1 Use of interleukin-24 to treat ovarian cancer
10/23/2003CA2479996A1 Compositions for delivering enyzmes involved in acid metabolism using recombinant adeno-associated virus virons (raav virons), and method and use for treating amino acid metabolicdisorders using such raav virons
10/23/2003CA2479519A1 Use of interleukin-19 to treat cervical cancer
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354952A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354896A1 Novel monoclonal antibody
10/22/2003EP1354893A2 Physiologically active complex
10/22/2003EP1354583A2 Aerosols containing beclomethasone nanoparticle dispersions
10/22/2003EP1354582A2 Emulsion preconcentrates containing cyclosporin or a macrolide
10/22/2003EP1354581A1 Porous substance and process for producing the same
10/22/2003EP1354518A1 Kernel oil from plant kernel, process for extracting same, pharmaceutical composition and use thereof
10/22/2003EP1354053A2 Polynucleotide encoding chimeric protein and related vectors, cells, and methods of expression thereof
10/22/2003EP1354001A2 Compositions containing copolymers based on acryloyldimethyl aminoethylsulfonic acid and synergistic additives
10/22/2003EP1354000A2 Use of comb copolymers based on acryloyldimethyltaurine acid in cosmetic, pharmaceutical and dermatological products
10/22/2003EP1353968A1 Linear block polymer
10/22/2003EP1353952A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
10/22/2003EP1353933A1 Method for purification of lactose
10/22/2003EP1353932A1 Compositions containing a ruthenium(iii) complex and a heterocycle
10/22/2003EP1353701A2 Methods and compositions for enhanced delivery of bioactive molecules
10/22/2003EP1353700A1 Compositions of estrogen-cyclodextrin complexes
10/22/2003EP1353699A1 Cyclodextrin-drospirenone inclusion complexes
10/22/2003EP1353698A1 Recombinant serum albumin for use in cleansing or dermatological products for skin or hair
10/22/2003EP1353697A1 Method of preparing biological materials and preparation produced using same
10/22/2003EP1353696A2 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
10/22/2003EP1353691A2 Molecular antigen array presenting amyloid beta
10/22/2003EP1353685A2 Controlled release pharmaceutical systems
10/22/2003EP1353668A1 Methods of administering epothilone analogs for the treatment of cancer
10/22/2003EP1353667A1 Parenteral formulations containing epothilone analogs
10/22/2003EP1353663A1 Fenofibrate tablets
10/22/2003EP1353659A1 Use of neurotoxic substances in producing a medicament for treating joint pains
10/22/2003EP1353651A2 Extended release pharmaceutical compositions containing beta-lactam antibiotics
10/22/2003EP1353650A2 Process for preparing non-hygroscopic sodium valproate composition
10/22/2003EP1353648A2 Microparticles of biodegradable polymer encapsulating a biologically active substance
10/22/2003EP1353647A2 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
10/22/2003EP1353629A2 Translucent nanoemulsion, production method, and uses thereof in the cosmetic, dermatological and/or ophthalmological fields
10/22/2003EP1353624A2 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
10/22/2003EP1196135B1 Compositions comprising organosiloxane resins for delivering oral care substances
10/22/2003EP1164996B1 Transdermal therapeutic system with nicotine and addition of monoterpene ketones
1 ... 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 ... 1712